Universal Time: 14:06  |  Local Time: 14:06 (3h GMT)
Select your timezone:

Clinical trials design and end-points in transplantation

Monday September 23, 2024 - 15:40 to 16:40

Room: Üsküdar 3

257.1 Innovative trial design in transplantation

Andrea Viecelli, Australia

Associate Professor, Clinical Trialist
Centre for Health Services Research, Australasian Kidney Trials Network
The University of Queensland


Associate Professor Andrea Viecelli is an academic nephrologist at Princess Alexandra Hospital and was awarded her PhD on strategies to improve vascular access outcomes in patients on haemodialysis in 2019 through the University of Queensland.
As a clinical trialist of the Australasian Kidney Trials Network (AKTN) she plays a key role in designing and conducting international clinical trials in people with chronic kidney disease.
As a Coordinating Committee member and Vascular Access Project Coordinator of the global SONG initiative, she is conducting clinical and qualitative research to establish standardised core outcome measures based on the shared priorities of patients, clinicians, researchers and policy makers from >100 countries to improve the relevance and reliability of kidney research to inform patient-centred care.
She has received numerous local, national and international awards for her research, including the ANZSN Young Investigator Award (2017), Kidney Health Australia Clinical Research Award (2016), the ERA EDTA Young Investigator award (2017 and 2018) and the 2018 Sylvan Green Award from the Society for Clinical Trials.
As the recipient of a National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant and a Queensland Advancing Clinical Research Fellowship she currently pursues a program of clinical and qualitative research to improve patient-important outcomes in haemodialysis.

Presentations by Andrea Viecelli

Social Media Promotion Image

right-click to download

© 2024 TTS 2024